Literature DB >> 24549838

Relationship between depressive symptoms and quality of life in Nigerian patients with schizophrenia.

Adesanmi Akinsulore1, Olutayo O Aloba, B M Mapayi, I O Oloniniyi, F O Fatoye, R O A Makanjuola.   

Abstract

PURPOSE: Quality of life (QOL) in patients with schizophrenia is influenced by various factors such as depressive symptoms. This study assessed the relationship between depressive symptoms and QOL in outpatients with schizophrenia in Nigeria and evaluated the associated socio-demographic and clinical factors.
METHODS: One hundred patients with 10th edition of the International Classification of Diseases diagnosis of schizophrenia participated in this study. Socio-demographic and clinical factors such as depression were assessed with Zung Self-rating Depression Scale and symptoms of schizophrenia with the Positive and Negative Syndrome Scale of schizophrenia (PANSS). The level of functioning was assessed with the Global Assessment of Functioning Scale. QOL was assessed using the brief version of the World Health Organisation Quality of Life Scale.
RESULTS: There were 27 (27.0 %) patients with depression. The depressed patients reported significant lower scores in all QOL domains when compared with the non-depressed group. All QOL domains were significantly negatively correlated with the total PANSS and all its subscales (except for psychological domain with total PANSS and social relationship and environmental domains with PANSS positive). Severity of depressive symptoms was significantly negatively correlated with all QOL domains. Functioning was significantly positively correlated with all QOL domains except in the environmental domain. Multiple regression analysis showed that depressive symptoms predicted all QOL domains except the social relationship domain while negative symptoms predicted social relationship and environmental domains.
CONCLUSION: Depression is a common occurrence during the course of schizophrenia. Depressive and negative symptoms have a significant impact on the QOL of patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549838     DOI: 10.1007/s00127-014-0838-8

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  37 in total

1.  Depression in schizophrenia: recognition and management in the USA.

Authors:  S G Siris; D Addington; J M Azorin; I R Falloon; J Gerlach; S R Hirsch
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Symptoms of depression in schizophrenia.

Authors:  T Murali; S Ravi Kumar
Journal:  Indian J Med Res       Date:  2008-06       Impact factor: 2.375

3.  Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients.

Authors:  B Carpiniello; G L Lai; C M Pariante; M G Carta; N Rudas
Journal:  Acta Psychiatr Scand       Date:  1997-10       Impact factor: 6.392

4.  Depression and the experience of psychological deficits in schizophrenia.

Authors:  P F Liddle; T R Barnes; D A Curson; M Patel
Journal:  Acta Psychiatr Scand       Date:  1993-10       Impact factor: 6.392

5.  Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs.

Authors:  Nancy C Andreasen; Marcus Pressler; Peg Nopoulos; Del Miller; Beng-Choon Ho
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

6.  Quality of life of Chinese schizophrenia outpatients in Hong Kong: relationship to sociodemographic factors and symptomatology.

Authors:  Yu-Tao Xiang; Yong-Zhen Weng; Chi-Ming Leung; Wai-Kwong Tang; Gabor S Ungvari
Journal:  Aust N Z J Psychiatry       Date:  2007-05       Impact factor: 5.744

7.  Emotional distress and its correlates among Nigerian women in late pregnancy.

Authors:  F O Fatoye; A B Adeyemi; B Y Oladimeji
Journal:  J Obstet Gynaecol       Date:  2004-08       Impact factor: 1.246

Review 8.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

Review 9.  The impact of mental illness on sexual dysfunction.

Authors:  Zvi Zemishlany; Abraham Weizman
Journal:  Adv Psychosom Med       Date:  2008

Review 10.  Questioning an axiom: better prognosis for schizophrenia in the developing world?

Authors:  Alex Cohen; Vikram Patel; R Thara; Oye Gureje
Journal:  Schizophr Bull       Date:  2007-09-28       Impact factor: 9.306

View more
  8 in total

1.  Relationship between quality of life and social integration among patients with schizophrenia attending a Nigerian tertiary hospital.

Authors:  Temitope Ogundare; Peter O Onifade; 'Deji Ogundapo; Senait Ghebrehiwet; Christina P C Borba; David C Henderson
Journal:  Qual Life Res       Date:  2021-02-01       Impact factor: 4.147

2.  Systematic review of global functioning and quality of life in people with psychotic disorders.

Authors:  A G Nevarez-Flores; K Sanderson; M Breslin; V J Carr; V A Morgan; A L Neil
Journal:  Epidemiol Psychiatr Sci       Date:  2018-10-01       Impact factor: 6.892

3.  The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia.

Authors:  Hidenobu Suzuki; Hiroyuki Hibino; Yuichi Inoue; Hideo Matsumoto; Katsunaka Mikami
Journal:  SAGE Open Med Case Rep       Date:  2017-05-26

4.  Prevalence, Influencing Factors, and Cognitive Characteristics of Depressive Symptoms in Elderly Patients with Schizophrenia.

Authors:  Yaopian Chen; Wei Li
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-14       Impact factor: 2.570

5.  Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?

Authors:  Conrad O Iyegbe; Anita Acharya; John Lally; Poonam Gardner-Sood; Louise S Smith; Shubulade Smith; Robin Murray; Oliver Howes; Fiona Gaughran
Journal:  NPJ Schizophr       Date:  2015-10-28

6.  Disability assessment as an outcome measure: a comparative study of Nigerian outpatients with schizophrenia and healthy control.

Authors:  Adesanmi Akinsulore; Boladale M Mapayi; Olutayo O Aloba; Ibidunni Oloniniyi; Femi O Fatoye; Roger O A Makanjuola
Journal:  Ann Gen Psychiatry       Date:  2015-11-23       Impact factor: 3.455

7.  Assigning Clinical Significance and Symptom Severity Using the Zung Scales: Levels of Misclassification Arising from Confusion between Index and Raw Scores.

Authors:  Debra A Dunstan; Ned Scott
Journal:  Depress Res Treat       Date:  2018-01-21

8.  Mediation and moderation analyses: exploring the complex pathways between hope and quality of life among patients with schizophrenia.

Authors:  Wei-Liang Wang; Yu-Qiu Zhou; Nan-Nan Chai; Guo-Hua Li; Dong-Wei Liu
Journal:  BMC Psychiatry       Date:  2020-01-15       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.